- Home
- FULC vs VREX Comparison
FULC vs VREX Comparison
Compare FULC & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FULC | VREX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.1M | 483.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | FULC | VREX |
|---|---|---|
| Price | $9.87 | $13.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $16.38 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.2M | 290.9K |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $844,600,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2752.05 | 4.14 |
| 52 Week Low | $2.32 | $6.76 |
| 52 Week High | $15.74 | $15.46 |
Technical Indicators
Market Signals| Indicator | FULC | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 72.88 |
| Support Level | $9.77 | $11.48 |
| Resistance Level | $10.47 | $12.14 |
| Average True Range (ATR) | 0.70 | 0.45 |
| MACD | -0.32 | 0.14 |
| Stochastic Oscillator | 8.63 | 86.12 |
Price Performance
Historical ComparisonAbout FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.